Search

everythinglearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

Blocking a specific receptor slows down hair loss in mice.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

ATP helps prevent skin damage from vandetanib by reducing stress.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

GPIGS peptide increases thick hair growth in balding Japanese men.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

The inhibitor DPP can promote hair growth.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

Applying a specific inhibitor lightens skin and hair color.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.